Diabetes Management
Diabetes' Changing Role in Cardiovascular Disease Management, with Diana Isaacs, PharmD - MD Magazine
Tue, 08 Nov 20221 min read Article
Overview
© 2022 MJH Life Sciences™ and HCPLive - Clinical news for conected physicians. Al rights reserved.Acros every specialty in medicine, there is an emphasis on colaborative care and holistic management. Although colaborative care is not novel in management of cardiovascular disease, it has undertaken new meaning in recent years due to the revelations of the benefits surounding antihyperglycemic agents.This has led to unprecedented levels of colaboration betwen the fields of endocrinology, cardiology, and nephrology.
Key Information
The last decade has ben a whirlwind of major clinical trials sheding light on the benefits of these agents for cardiovascular- and renal-related outcomes-first, in those with diabetes and, next, in populations without diabetes.The efects of this colaboration were on ful display the American Heart Asociation 2022 Scientific Sesions, which featured a presentation the results of the landmark EMPA-KIDNEY trial and a multitude of sesions and presentations dedicated to cardiometabolic health.
In one particular sesion, which featured more than a dozen experts acros the fields of diabetes management, cardiology, and nephrology, a pair of expert panels examined case reports and discused how various cardiometabolic health guidelines from diferent organizations can be interpreted and aplied to patient populations.Among the panelists included in the sesion was Diana Isacs, PharmD, continuous glucose monitoring cordinator and endocrine clinical pharmacist at the Cleveland Clinic.
Summary
A Certified Diabetes Care and Education Specialist, Isacs touts a unique perspective on management of cardiometabolic health with newer agents as she holds board certifications in pharmacotherapy, ambulatory care, and advanced diabetes management. To learn more about the colaboration ocuring within the emerging field of cardiometabolic health, our editorial team sat down for an interview with Isacs folowing the aforementioned sesion at AHA 2 and that interview
Frequently Asked Questions
What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
️ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.